MedTrace Logo

The Antidepressive Effect of rTMS as add-on to ECT

NCT02123485 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-02-23

Study results available
· View outcomes & findings →

Summary

The aim of the present study is to investigate in which degree low frequency right prefrontal rTMS used ad add-on may potentiate the antidepressant effect of unilateral ECT and accelerate remission .

To investigate the correlation between blood concentration of specific inflammation makers and change in depressive symptoms during treatment

Conditions

Interventions

DEVICE

Low frequency (1 hz) rTMS, as add-on to ECT

Right prefrontal Low frequency (1 hz) repetitive transcranial magnetic stimulation as add-on to ECT.

DEVICE

Sham-rTMS

Right prefrontal Low frequency (1 hz) sham-stimulation using af double blind placebo coil as add-on to ECT.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Poul Erik Buchholtz, MD · Poul Erik Buchholtz, MD Telephone: 004578472109 Email: [email protected]

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02123485 on ClinicalTrials.gov